This paper is only available as a PDF. To read, Please Download here.
Abstract
A prospective study was undertaken to evaluate the postoperative pain and analgesic
profiles of a group of 50 patients undergoing outpatient anterior cruciate ligament
(ACL) reconstruction and to compare their profiles with those of a group of 50 patients
undergoing outpatient non- ACL arthroscopic surgery. All patients received preoperative
and postoperative ketorolac, intraincisional/intra-articular bupivacaine, intraoperative
ketorolac, and propofol anesthetic. The percentage of patients receiving supplemental
analgesia in the recovery room was 49% (average, 2.2 mg intravenous morphine sulfate)
for the ACL group and 31% (average, 1.2 mg intravenous morphine sulfate) in the non-ACL
group. Narcotic use and pain scores peaked in both groups on postoperative days 1
and 2. The ACL group used significantly more narcotic and had higher pain scores in
the first week after surgery than did the non-ACL group. However, there were no subsequent
admissions, readmissions, or emergency room visits for pain. All were satisfied with
the outpatient nature of this surgery. Patients tolerate outpatient endoscopic ACL
reconstruction with moderate pain and narcotic use. Outpatient endoscopic ACL reconstruction
can be performed safely, effectively, and with considerable cost savings.
Arthroscopy 1998 Sep;14(6):613-6
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ArthroscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 1998 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.
